Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Target (TGT) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Kate McShane saying Target has gained share across all categories over the past 18 months supporting double digit sales growth and "outsized" operating income growth, but the pace of its revenue growth should slow into 2022 to be in-line with historical levels. 2. US Ecology (ECOL) downgraded to Hold from Buy at Stifel with analyst Michael Hoffman saying 2021 has "proven less predictable" for waste services companies and another cut in guidance possible for US Ecology is possible. 3. Williams (WMB) downgraded to Peer Perform from Outperform at Wolfe Research with analyst Alex Kania citing valuation for the downgrade with the target reflecting less upside potential. 4. Marriott (MAR) downgraded to In Line from Outperform at Evercore ISI with analyst Rich Hightower calling his change in rating "simply a valuation call" after hotel stocks' "nice outperformance streak" over the past 30 to 60 days. 5. Akero Therapeutics (AKRO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Michael Ulz saying while he believes efruxifermen has "a differentiated, best-in-class profile," negative investor sentiment on the nonalcoholic steatohepatitis, space and a lack of near-term catalysts keep him on the sidelines. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.